Advertisement
Home Tags Tuberculosis

Tag: Tuberculosis

Dexamethasone No Benefit in HIV-Positive With Tuberculous Meningitis

No survival benefit or benefit in any secondary end point seen for adjunctive dexamethasone versus placebo

USPSTF Recommends Screening At-Risk Persons for Latent TB Infection

Moderate net benefit found for preventing active tuberculosis disease by screening persons at increased risk for infection

USPSTF Recommends Screening At-Risk Persons for Latent TB Infection

Moderate net benefit found for preventing active tuberculosis disease by screening persons at increased risk for infection

Mortality High for Patients With Concurrent TB, COVID-19

In adjusted analysis, 31 percent of people with concurrent diseases died

Incidence of Tuberculosis Up to 2.5 Cases Per 100,000 in U.S. in 2022

Compared with 2021, in 2022, TB incidence was higher among persons aged 4 years and younger and 15 to 24 years and lower in those aged 65 years and older

Eight-Week Bedaquiline-Linezolid Noninferior for TB

Eight-week treatment noninferior to standard regimen for composite of death, ongoing treatment, active disease at week 96

USPSTF Recommends Screening for Latent TB Infection

Task force recommends screening asymptomatic adults at increased risk for latent TB infection

Bedaquiline-Pretomanid-Linezolid Regimens Compared for XDR TB

Overall risk-benefit ratio seems to favor patients receiving linezolid at dose of 600 mg for 26 weeks

Multidose BCG Protects Against COVID-19 in At-Risk Individuals

Efficacy of 92 percent found among at-risk COVID-19-unvaccinated individuals with type 1 diabetes

Among Persons With HIV, More Finish Short-Course TB Prophylaxis

Treatment completion 90.4 percent for three months of rifapentine-isoniazid versus 50.5 percent for six months of isoniazid